Therefore, these two enzymes are regarded as the most important targets for candidate drugs of AD, and previous studies have shown the rescue effects on Aβ production when the familial AD patient iPSC‐derived neurons were treated with BSI (BACE1 inhibitor).12, 40. This evidence concerns the gene BACE1 and Alzheimer disease.